AMICUS THERAPEUTICS, INC. — Director's Dealing 2016

Sep 22, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2016-09-20

Reporting Person: Baird William D III (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-09-20	Common Stock	M	3500	$8.00	Acquired	56450	Direct
2016-09-20	Common Stock	S	3500	$8.00	Disposed	52950	Direct
2016-09-20	Common Stock	S	17000	$8.0044	Disposed	35950	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-09-20	Stock Options (right to buy)	$2.45	M	3500	Disposed	2024-01-03	Common Stock (3500)	Direct

Footnotes

F1: The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2016

F2: The sale of shares of common stock were made pursuant to a J.P. Morgan Securities LLC Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2016

F3: This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $8.00 to $8.04. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.